Patents
Patents for C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
10/2013
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/01/2013US8546569 Chemical compounds
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
09/2013
09/25/2013CN103328470A Process for the preparation of diol sulfones
09/19/2013WO2013135674A1 Insecticidal 2-aryl-acetamide compounds
09/18/2013CN103313984A Methyltetrazole sulfides and sulfones
09/18/2013CN103313983A Process for the preparation of statins in the presence of base
09/17/2013US8536340 Cross-linked cyclic amine compounds and agents for pest control
09/17/2013US8536182 Benzylpiperazine derivatives and their medical use
09/03/2013US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
08/2013
08/29/2013WO2013098229A3 Heteroarylpiperidine and piperazine derivatives as fungicides
08/28/2013CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors
08/21/2013CN101522674B Novel compounds, pharmaceutically acceptable salts as vanilloid receptor antagonist and pharmaceutical composition comprising the compounds
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
07/2013
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/02/2013US8476455 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
06/2013
06/26/2013CN103172578A 4-ring end substituted 2-1,2,3-triazole phenylamines compound, preparation and purpose
06/11/2013US8461159 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
05/2013
05/29/2013EP2597089A1 Tricyclic heterocyclic compounds
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/21/2013US8445690 Aminothiazolones as estrogen related receptor-alpha modulators
05/21/2013US8445683 Porphyrin compounds comprising one or more pyridone moieties
05/16/2013US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections
05/15/2013EP2592071A1 Tricyclic heterocyclic compounds
05/02/2013US20130109656 Mitotic kinesin inhibitors and methods of use thereof
04/2013
04/30/2013CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors
04/23/2013US8426604 Aminothiazolones as estrogen related receptor-alpha modulators
04/23/2013US8426424 Certain substituted amides, method of making, and method of use thereof
04/23/2013US8426409 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk
04/23/2013US8426404 e.g. 3-[1-(6-Amino-pyrimidin-4-yl)-1H-benzoimidazol-2-ylamino]-4-methyl-N-[4-(2-methyl-imidazol-1-yl)-3-trifluoromethyl-phenyl]-benzamide; receptor and non-receptor tyrosine kinases and serine/threonine kinases inhibitor; antiproliferative agent; immune and nervous system disorders
04/16/2013US8420661 Arylethynyl derivatives
04/09/2013US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents
03/2013
03/26/2013US8404708 Dual NK1/NK3 receptor antagonists
03/20/2013EP2569310A1 Morpholine compounds as mineralocorticoid receptor antagonists
03/14/2013WO2012173682A3 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
03/12/2013US8394807 Quinazoline inhibitors of BACE 1 and methods of using
02/2013
02/19/2013US8378115 Monomethine dyes
01/2013
01/24/2013US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
01/16/2013CN102876323A Cadmium ion fluorescence probe, preparation method and application
01/10/2013WO2013006485A1 Fused benzoxazepinones as ion channel modulators
01/10/2013US20130012492 Fused heterocyclic compounds as ion channel modulators
01/10/2013CA2838223A1 Fused benzoxazepinones as ion channel modulators
01/08/2013US8350048 Amide compounds as boosters of antivirals
01/08/2013US8349859 Pyrimidine derivatives
01/08/2013CA2478731C Carbamates as hiv protease inhibitors
01/01/2013US8343913 Hsp90, buffering and drug resistance
12/2012
12/20/2012WO2012173682A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases
12/11/2012US8329924 Compounds and methods for the treatment or prevention of Flavivirus infections
12/04/2012US8324133 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/2012
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/15/2012WO2012153775A1 Thioxothiazolidine derivative having ras function inhibitory effect
10/2012
10/30/2012US8299258 Method of making piperidine derivatives
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/16/2012CA2496477C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/10/2012EP2507230A1 Insecticidal compounds based on isoxazoline derivatives
10/04/2012WO2012130306A1 Bicyclic 2,3-dihyrdobenzazine compounds for use in therapy
10/03/2012CN102712628A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/2012
09/25/2012US8273777 Glucokinase activators and methods of using same
09/20/2012US20120238517 Insecticidal compounds based on isoazoline derivatives
09/19/2012EP2499132A1 Hepatitis c virus inhibitors
09/19/2012CN102686571A Tricyclic heterocyclic compounds
09/19/2012CN101528740B Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
09/18/2012US8268809 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
09/13/2012WO2012120135A1 Isoxazole derivatives
09/13/2012WO2012120058A1 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120057A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012WO2012120056A1 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120055A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120050A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012CA2829149A1 Isoxazole derivatives
09/11/2012US8263624 Aryl-substituted heterocycles, and use thereof
09/05/2012EP2493866A1 Tricyclic heterocyclic compounds
08/2012
08/23/2012WO2012025213A3 Novel therapeutic compounds
08/15/2012CN102639529A Insecticidal compounds based on isoxazoline derivatives
08/14/2012US8242273 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
08/02/2012WO2012102255A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
07/2012
07/31/2012US8232285 Quinazolinone compounds and methods of use thereof
07/26/2012WO2012098050A1 Methyltetrazole sulfides and sulfones
07/26/2012WO2012098049A1 Process for the preparation of statins in the presence of base
07/26/2012WO2012098048A1 Process for the preparation of diol sulfones
07/18/2012EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors
07/11/2012EP2473490A1 (thio)morpholine derivatives as s1p modulators
07/11/2012CN102558155A 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
07/04/2012CN102548976A (Thio) morpholine derivatives as S1P modulators
06/2012
06/26/2012US8207164 Oxazine derivatives and their use in the treatment of neurological disorders
06/19/2012US8203001 Chemical compounds
06/19/2012US8202876 Compounds and compositions as protein kinase inhibitors
06/12/2012US8198281 Crystalline forms of dihydropyrazolopyrimidinone
06/07/2012US20120142676 Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
06/06/2012CN1545508B 1,2,4-trioxolane antimalarials
06/05/2012US8191802 Aerosol
05/2012
05/30/2012EP2457906A1 Derivatives of 1,2,4-benzothiadiazine dioxide, their preparation and use as allosteric modulators of the AMPA receptor
05/09/2012CN101137653B Thiazole-4-carboxamide derivatives as MGLUR5 antagonists
05/03/2012WO2011162514A3 Method for preparing [1,2,3]-oxathiazolidine-2,2-dioxide or [1,2,5]-thiadiazolidine-1,1-dioxide derivatives
04/2012
04/24/2012US8163753 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria
04/17/2012CA2450007C Compounds and methods for the treatment or prevention of flavivirus infections
04/10/2012US8153682 Sulfonamides as TRPM8 modulators
03/2012
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 ... 15